Novo Nordisk A/S (CPH:NOVO.B)
350.00
-10.50 (-2.91%)
Sep 5, 2025, 4:59 PM CET
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
3.98M DKK
Profits / Employee
1.42M DKK
Market Cap
1,555.20B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Coloplast | 16,639 |
Genmab | 2,682 |
Demant | 22,639 |
ALK-Abelló | 2,753 |
H. Lundbeck | 5,707 |
Zealand Pharma | 335 |
Ambu A/S | 5,196 |
Bavarian Nordic | 1,605 |
Novo Nordisk News
- 2 hours ago - Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PRNewsWire
- 4 hours ago - Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data - Benzinga
- 5 hours ago - Novo Nordisk Vs Eli Lilly: Novo A Clear Winner - Seeking Alpha
- 9 hours ago - Novo Nordisk A/S Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights - NVO - PRNewsWire
- 16 hours ago - Novo Nordisk to present new semaglutide data on ‘food noise', body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress - GlobeNewsWire
- 1 day ago - Novo Nordisk A/S Class Action: The Gross Law Firm Reminds Novo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 – NVO - GlobeNewsWire
- 1 day ago - Novo Nordisk (NVO) Explores Ozempic's Potential in Alzheimer's Treatment - GuruFocus
- 1 day ago - Novo Nordisk Is a Strong Buy After the 2025 Pullback - FX Empire